The Gillett Health Podcast cover image

Semaglutide VS Tirzepatide | The Gillett Health Podcast #76

The Gillett Health Podcast

CHAPTER

Intro

The chapter includes ads for Nuculus Network seeking participants with moderate to severe kidney impairment for studies offering compensation from $2,000 to $7,000, and Baker's Pharmacy showcasing their convenient care services such as evening hours, insurance acceptance, and online prescription management.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner